Gliomas are the most common central nervous system tumors. New technologies, including
genetic research and advanced statistical methods, revolutionize the therapeutic approach …

Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely
investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence …

Glioblastoma multiforme (GBM) is the most common and lethal cancer of the adult brain,
remaining incurable with a median survival time of only 15 months. In an effort to identify …

Glioblastoma (GBM) is the most aggressive, deadliest, and most common brain malignancy
in adults. Despite the advances made in surgical techniques, radiotherapy and …

Aberrant expression of noncoding RNAs in glioma cells, including long noncoding RNAs
(lncRNAs) and microRNAs, may participate in the progression of glioma. Encoded by …

Glioblastoma (GBM) is the most common primary tumor of the central nervous system.
Arising from neuroepithelial glial cells, GBM is characterized by invasive behavior, extensive …

Glioblastoma (GBM), also known as grade IV astrocytoma, is the most aggressive primary
intracranial tumor of the adult brain. MicroRNAs (miRNAs), a class of small non-coding RNA …

Glioblastoma (GBM), the most aggressive and lethal brain cancer, is detected only in the
advanced stage, resulting in a median survival rate of 15 months. Therefore, there is an …

Malignant gliomas are aggressive brain tumors with limited therapeutic options, possibly
because of highly tumorigenic subpopulations of glioma stem cells. These cells require …

Ferroptosis, a novel mode of cell death dependent on iron and reactive oxygen species, has
been extensively explored during malignant tumors metastasis. Ferroptosis can interact with …